Uses and challenges of bioinformatic tools in mass spectrometric-based proteomic brain perturbation studies

International Journal of Bioinformatics Research and Applications

Volumn 10, Issue 1, 2014, Pages 27-42

  Guingab Cagmat, Joy D ^a   Cagmat, Emilio B ^a   Kobeissy, Firas H ^b   Anagli, John ^a  

^a BANYAN BIOMARKERS INC   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Bioinformatics; Biomarkers; Data mining; Mass spectrometry; Proteomics; Traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

ALGORITHM; ANIMAL; ARTICLE; BIOINFORMATICS; BIOLOGY; BRAIN; BRAIN INJURY; COMPUTER PROGRAM; DATA MINING; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; PEPTIDE MAPPING; PROTEOMIC BRAIN PERTURBATION; PROTEOMICS; TRAUMATIC BRAIN INJURY;

BIOINFORMATICS; BIOMARKERS; DATA MINING; MASS SPECTROMETRY; PROTEOMIC BRAIN PERTURBATION; PROTEOMICS; TRAUMATIC BRAIN INJURY;

ALGORITHMS; ANIMALS; BRAIN; BRAIN INJURIES; COMPUTATIONAL BIOLOGY; HUMANS; PEPTIDE MAPPING; PROTEOME; PROTEOMICS; SOFTWARE;

EID: 84892847860     PISSN: 17445485     EISSN: 17445493     Source Type: Journal    
DOI: 10.1504/IJBRA.2014.058776     Document Type: Article

References (45)

1. Agoston, D.V., Gyorgy, A., Eidelman, O. and Pollard, H.B. (2009) 'Proteomic biomarkers for blast neurotrauma: targeting cerebral edema, inflammation, and neuronal death cascades', Journal of Neurotrauma, Vol. 26, pp.901-911.
2. Cataldo, J.K., Prochaska, J.J. and Glantz, S.A. (2010) 'Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation', Journal of Alzheimer's Disease, Vol. 19, pp.465-480.
3. Denslow, N., Michel, M.E., Temple, M.D., Hsu, C.Y., Saatman, K. and Hayes, R.L. (2003) 'Application of proteomics technology to the field of neurotrauma', Journal of Neurotrauma, Vol. 20, pp.401-407.
4. Elias, J.E. and Gygi, S.P. (2009) 'Target-decoy search strategy for mass spectrometry-based proteomics', Methods in Molecular Biology, Vol. 604, pp.55-71.
5. Frank, A. and Pevzner, P. (2005) 'PepNovo: de novo peptide sequencing via probabilistic network modeling', Analytical Chemistry, Vol. 77, pp.964-973.
6. Fuller, B.F., Gold, M.S., Wang, K.K. and Ottens, A.K. (2010) 'Effects of environmental tobacco smoke on adult rat brain biochemistry', Journal of Molecular Neuroscience, Vol. 41, pp.165-171.
7. Gold, M.S., Kobeissy, F.H., Wang, K.K., Merlo, L.J., Bruijnzeel, A.W., Krasnova, I.N. and Cadet, J.L. (2009) 'Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates', Biological Psychiatry, Vol. 66, pp.118-127.
8. Guingab-Cagmat, J., Bauzo, R.M., Bruijnzeel, A.W., Wang, K.K., Gold, M.S. and Kobeissy, F.H. (2012a) 'Methods in tobacco abuse: proteomic changes following second-hand smoke exposure', Methods in Molecular Biology, Vol. 829, pp.329-348.
9. Guingab-Cagmat, J.D., Newsom, K., Vakulenko, A., Cagmat, E., Kobeissy, F., Zoltewicz, S., Wang, K. and Anagli, J. (2012b) 'An in vitro mass spectrometry-based proteomic analysis and absolute quantification of neuronal-glial injury biomarkers in cell culture system', Electrophoresis.
10. Guingab-Cagmat, J.D., Stevens Jr., S.M., Ratliff, M.V., Zhang, Z., Gold, M.S., Anagli, J., Wang, K.K. and Kobeissy, F.H. (2011) 'Identification of tyrosine nitration in UCH-L1 and GAPDH', Electrophoresis, Vol. 32, pp.1692-1705.
11. Keller, A., Nesvizhskii, A.I., Kolker, E. and Aebersold, R. (2002) 'Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search', Analytical Chemistry, Vol. 74, pp.5383-5392.
12. Kobeissy, F.H., Ottens, A.K., Zhang, Z., Liu, M.C., Denslow, N.D., Dave, J.R., Tortella, F.C., Hayes, R.L. and Wang, K.K. (2006) 'Novel differential neuroproteomics analysis of traumatic brain injury in rats', Molecular & Cellular Proteomics, Vol. 5, pp.1887-1898.
13. Kobeissy, F.H., Sadasivan, S., Liu, J., Gold, M.S. and Wang, K.K. (2008a) 'Psychiatric research: psychoproteomics, degradomics and systems biology', Expert Review of Proteomics, Vol. 5, pp.293-314.
14. Kobeissy, F.H., Sadasivan, S., Oli, M.W., Robinson, G., Larner, S.F., Zhang, Z., Hayes, R.L. and Wang, K.K. (2008b) 'Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation', Proteomics - Clinical Applications, Vol. 2, pp.1467-1483.
15. Kobeissy, F.H., Warren, M.W., Ottens, A.K., Sadasivan, S., Zhang, Z., Gold, M.S. and Wang, K.K. (2008c) 'Psychoproteomic analysis of rat cortex following acute methamphetamine exposure', Journal of Proteome Research, Vol. 7, pp.1971-1983.
16. Kochanek, P.M., Berger, R.P., Bayir, H., Wagner, A.K., Jenkins, L.W. and Clark, R.S. (2008) 'Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making', Current Opinion in Critical Care, Vol. 14, pp.135-141.
17. Kwon, S.K., Kovesdi, E., Gyorgy, A.B., Wingo, D., Kamnaksh, A., Walker, J., Long, J.B., Agoston, D V. (2011) 'Stress and traumatic brain injury: a behavioral, proteomics, and histological study', Frontiers in Neurology, Vol. 2, p.12.
18. Lista, S., Faltraco, F. and Hampel, H. (2012) 'Blood and plasma-based proteomic biomarker research in Alzheimer's disease', Progress in Neurobiology, Nos. 101/102, pp.1-17.
19. Liu, H., Sadygov, R.G. and Yates 3rd, J.R. (2004) 'A model for random sampling and estimation of relative protein abundance in shotgun proteomics', Analytical Chemistry, Vol. 76, pp.4193-4201.
20. Ma, B., Zhang, K., Hendrie, C., Liang, C., Li, M., Doherty-Kirby, A. and Lajoie, G. (2003) 'PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometry', Rapid Communications in Mass Spectrometry, Vol. 17, pp.2337-2342.
21. Mann, M. and Wilm, M. (1994) 'Error-tolerant identification of peptides in sequence databases by peptide sequence tags', Analytical Chemistry, Vol. 66, pp.4390-4399.
22. Maurer, M.H. (2010) 'Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF)', Mass Spectrometry Review, Vol. 29, pp.17-28.
23. Morgan, J.C., Mehta, S.H. and Sethi, K.D. (2010) 'Biomarkers in Parkinson's disease', Current Neurology and Neuroscience Reports, Vol. 10, pp.423-430.
24. Nesvizhskii, A.I., Keller, A., Kolker, E. and Aebersold, R. (2003) 'A statistical model for identifying proteins by tandem mass spectrometry', Analytical Chemistry, Vol. 75, pp.4646-4658.
25. Ottens, A.K., Kobeissy, F.H., Fuller, B.F., Liu, M.C., Oli, M.W., Hayes, R.L. and Wang, K.K. (2007) 'Novel neuroproteomic approaches to studying traumatic brain injury', Progress in Brain Research, Vol. 161, pp.401-418.
26. Ottens, A.K., Kobeissy, F.H., Wolper, R.A., Haskins, W.E., Hayes, R.L., Denslow, N.D. and Wang, K.K. (2005) 'Neuroproteomics in neurotrauma', Analytical Chemistry, Vol. 77, pp.4836-4845.
27. Ottens, A.K., Kobeissy, F.H., Golden, E.C., Zhang, Z., Haskins, W.E., Chen, S.S., Hayes, R.L., Wang, K.K. and Denslow, N.D. (2006) 'A multidimensional differential proteomic platform using dual-phase ion-exchange chromatography-polyacrylamide gel electrophoresis/reversedphase liquid chromatography tandem mass spectrometry', Mass Spectrometry Review, Vol. 25, pp.380-408.
28. Prieto, D.A., Ye, X. and Veenstra, T.D. (2008) 'Proteomic analysis of traumatic brain injury: the search for biomarkers', Expert Rev Proteomics, Vol. 5, pp.283-291.
29. Prokai, L., Stevens Jr., S.M., Rauniyar, N. and Nguyen, V. (2009) 'Rapid label-free identification of estrogen-induced differential protein expression in vivo from mouse brain and uterine tissue', Journal of Proteome Research, Vol. 8, pp.3862-3871.
30. Robinson, P.A. (2010) 'Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy', Expert Review of Proteomics, Vol. 7, pp.565-578.
31. Rong, X.F. and Wang, X.L. (2012) 'An overview of biomarkers in Alzheimer's disease', Yao Xue Xue Bao, Vol. 47, pp.551-557.
32. Schuhmann, M.U., Heine, G., Skardelly, M., Jaeger, M. and Selle, H. (2005) 'Brain injury and proteomics/peptidomics: is it relevant? an overview', Acta Neurochirurgica Supplement, Vol. 95, pp.465-470.
33. Searle, B.C. (2010) 'Scaffold: a bioinformatic tool for validating MS/MS-based proteomic studies', Proteomics, Vol. 10, pp.1265-1269.
34. Shadforth, I., Crowther, D. and Bessant, C. (2005) 'Protein and peptide identification algorithms using MS for use in high-throughput, automated pipelines', Proteomics, Vol. 5, pp.4082-4095.
35. Sultana, R., Boyd-Kimball, D., Cai, J., Pierce, W.M., Klein, J.B., Merchant, M., Butterfield, D.A. (2007) 'Proteomics analysis of the Alzheimer's disease hippocampal proteome', Journal of Alzheimer's Disease, Vol. 11, pp.153-164.
36. Tanaka, K., Miyake, Y., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., Sakae, N., Fukuyama, H., Hirota, Y. and Nagai, M. (2010) 'Active and passive smoking and risk of Parkinson's disease', Acta Neurologica Scandinavica, Vol. 122, pp.377-382.
37. Wang, K.K., Ottens, A., Haskins, W., Liu, M.C., Kobeissy, F., Denslow, N., Chen, S. and Hayes, R.L. (2004) 'Proteomics studies of traumatic brain injury', International Review of Neurobiology, Vol. 61, pp.215-240.
38. Wang, K.K., Ottens, A.K., Liu, M.C., Lewis, S.B., Meegan, C., Oli, M.W., Tortella, F.C. and Hayes, R.L. (2005) 'Proteomic identification of biomarkers of traumatic brain injury', Expert Review of Proteomics, Vol. 2, pp.603-614.
39. Wilkins, M.R., Pasquali, C., Appel, R.D., Ou, K., Golaz, O., Sanchez, J.C., Yan, J.X., Gooley, A.A., Hughes, G., Humphery-Smith, I., Williams, K.L. and Hochstrasser, D.F. (1996) 'From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis', Biotechnology, Vol. 14, pp.61-65.
40. Xu, C. and Ma, B. (2006) 'Software for computational peptide identification from MS-MS data', Drug Discovery Today, Vol. 11, pp.595-600.
41. Yates 3rd, J.R., Eng, J.K., McCormack, A.L. and Schieltz, D. (1995) 'Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database', Analytical Chemistry, Vol. 67, pp.1426-1436.
42. Zabel, C., Mao, L., Woodman, B., Rohe, M., Wacker, M.A., Klare, Y., Koppelstatter, A., Nebrich, G., Klein, O., Grams, S., Strand, A., Luthi-Carter, R., Hartl, D., Klose, J. and Bates, G.P. (2009) 'A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for Huntington disease', Molecular & Cell Proteomics, Vol. 8, pp.720-734.
43. Zabel, C., Nguyen, H.P., Hin, S.C., Hartl, D., Mao, L. and Klose, J. (2010) 'Proteasome and oxidative phoshorylation changes may explain why aging is a risk factor for neurodegenerative disorders', Journal of Proteomics, Vol. 73, pp.2230-2238.
44. Zabel, C., Sagi, D., Kaindl, A.M., Steireif, N., Klare, Y., Mao, L., Peters, H., Wacker, M.A., Kleene, R. and Klose, J. (2006) 'Comparative proteomics in neurodegenerative and nonneurodegenerative diseases suggest nodal point proteins in regulatory networking', J.Proteome Res., Vol. 5, pp.1948-1958.
45. Zhang, X., Guo, T., Wang, H., He, W., Mei, H., Hong, M., Yu, J., Hu, Y. and Song, S. (2008) 'Potential biomarkers of acute cerebral infarction detected by SELDI-TOF-MS', American Journal of Clinical Pathology, Vol. 130, pp.299-304.